Delivery Order SPE2DB22D3019-SPE2DB25FK3UH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $48.5K to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injections on September 8, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 9, 2025, and performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $13,780.15 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on July 21, 2025, with completion targeted for July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors valued at $2,934.71. This is a firm fixed-price delivery order with an ultimate completion date of July 18, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,713.89 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injections on June 2, 2025, with an ultimate completion date of June 3, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $4,439.29 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injectors with a completion date of July 29, 2025. This firm fixed-price delivery order, issued on July 28, 2025, represents a competitively awarded contract with no set-aside designation. The product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $13,172.65 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,266.02 to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections with an ultimate completion date of May 5, 2025. This firm fixed-price delivery order was awarded on a non-competitive basis and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The IDC, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $5,441.80 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 27, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $5,496.91 delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pen injections on May 30, 2025, with a completion date of June 2, 2025. This firm fixed price contract is non-set-aside and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp was awarded a $1,040.19 delivery order by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. This is a firm fixed-price contract with an ultimate completion date of September 26, 2025, and represents performance at the company's Conshohocken, Pennsylvania headquarters. The award was competitively procured with no set-aside designation and serves as a child contract under AmerisourceBergen's larger...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK3UHDelivery Order
The Defense Logistics Agency awarded a $10,988.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injections. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by June 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026. AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio includes diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The broader SPE2DX IDC vehicle enables AmerisourceBergen to supply pharmaceutical products and medical commodities to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The Mounjaro delivery under this award contributes to the company's ongoing role in fulfilling critical pharmaceutical needs across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 6/12/25 |